Knee Pain Management Market Size, Share & Growth Report 2031

Segments - Knee Pain Management Market by Types (Acute Knee Pain and Chronic Knee Pain), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and E-commerce), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

Knee Pain Management Market Outlook 2031

The Knee Pain Management Market was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 5% during 2023 – 2031. The growth of the market is attributed to the surge in the frequency of sports injuries, the aging population, and the global patient pool are all driving global demand for knee pain management. High prevalence and incidence of osteoarthritis and rheumatoid arthritis among adult and geriatric populations.

Knee pain is a common ailment caused by the knee's bone structure. It is closely correlated with age. The location of knee pain is determined by the injured area. Limping owing to discomfort, trouble walking, climbing stairs, locking of the knee, redness, swelling, and inability to extend the knee are all symptoms of knee pain. Knee discomfort in young people is related to the overuse of knee joints as a result of physical activity or sports. It is caused by the wear and tear of the knee joint caused by osteoarthritis and rheumatoid arthritis in the elderly population.

Patients' usual lifestyles are hampered by their loss of movement and knee pain, necessitating the use of knee pain management and treatments right away. Mild knee discomfort merely causes inconvenience in daily life, however severe knee pain causes serious movement limitations. Damaged menisci, tendinitis, pseudogout, bursitis, and excess body weight are some of the other causes of knee pain.

Knee Pain Management Market Trends, Drivers, Restraints, and Opportunities

Rising frequency of sports injuries, the prevalence of arthritis, and the demand for treatment alternatives for the knee pain management market are expected to boost the market growth during the forecast period.
The growing aging population, as well as the risk of infections and swellings in the knee, are all projected to propel the market expansion in the coming years.
High prevalence and incidence of osteoarthritis and rheumatoid arthritis among adult and geriatric populations are estimated to spur the market growth in the coming years.
Emerging therapies, such as Disease-modifying antirheumatic drugs (DMARDs) and anti-NGF, are expected to grow the global market since they allow rapid pain relief and improved knee movement in patients.
High treatment costs, unfavorable reimbursement mainly for viscosupplementation, and generic competition are projected to impede the market expansion.
Technological developments in joint replacement are expected to create significant opportunities in the global knee pain management market.

Scope of Knee Pain Management Market Report

The report on the global knee pain management market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Knee Pain Management Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Types (Acute Knee Pain and Chronic Knee Pain), and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and E-commerce)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Johnson & Johnson Services, Inc., F. Hoffman-La Roche AG, Amgen, Inc., Merck & Co., Inc., and Pfizer, Inc., Ferring B.V., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Sanofi S.A., Zydus Cadila, and Others

Global Knee Pain Management Market Segment Insights

Chronic Knee Pain segment is projected to account for a large market share

Based on types, the global knee pain management market is bifurcated into acute knee pain and chronic knee pain. The chronic knee pain segment is expected to account for a key share of the market during the forecast period due to an increase in the number of surgeries performed globally and an increase in the prevalence of chronic disorders that cause knee pain.

Hospital Pharmacies segment is expected to represent a key market share

On the basis of distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, drug stores, and E-commerce. The hospital pharmacies segment is expected to constitute a key share of the market during the forecast period owing to the high number of patients visiting hospitals for knee pain treatments and the huge choice of knee pain treatments accessible in hospital pharmacy, hospital pharmacies accounted for the greatest proportion of the market, another significant benefit is the ease with which reimbursements can be obtained for purchases made at hospital pharmacies.

Knee Pain Management Market Distribution Channels

North America is anticipated to dominate the market
In terms of regions, the global knee pain management market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market at a healthy CAGR during the forecast period. The regional market growth can be attributed to the increased incidence of knee arthritis, which includes knee osteoarthritis and rheumatoid arthritis, rise in healthcare spending, an increase in knee ligament injuries, and a demand for better treatment.

Segments

The global knee pain management market has been segmented based on

Types

Acute Knee Pain
Chronic Knee Pain

Distribution Channels

Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-commerce

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Johnson & Johnson Services, Inc.
F. Hoffman-La Roche AG
Amgen, Inc.
Merck & Co., Inc.
Pfizer, Inc.
Ferring B.V.
GlaxoSmithKline plc
Bayer AG
AstraZeneca
Sanofi S.A.
Zydus Cadila
Others

Competitive Landscape

Leading manufacturers operating in the global knee pain management market include Johnson & Johnson Services, Inc., F. Hoffman-La Roche AG, Amgen, Inc., Merck & Co., Inc., and Pfizer, Inc., Ferring B.V., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Sanofi S.A., Zydus Cadila, and Others.

Knee Pain Management Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Knee Pain Management Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Knee Pain Management Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Knee Pain Management Market - Supply Chain
  4.5. Global Knee Pain Management Market Forecast
     4.5.1. Knee Pain Management Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Knee Pain Management Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Knee Pain Management Market Absolute $ Opportunity
5. Global Knee Pain Management Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Knee Pain Management Market Size and Volume Forecast by Types
     5.3.1. Acute Knee Pain
     5.3.2. Chronic Knee Pain
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Knee Pain Management Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Knee Pain Management Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Knee Pain Management Demand Share Forecast, 2019-2026
7. North America Knee Pain Management Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Knee Pain Management Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Knee Pain Management Market Size and Volume Forecast by Types
     7.4.1. Acute Knee Pain
     7.4.2. Chronic Knee Pain
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Knee Pain Management Demand Share Forecast, 2019-2026
8. Latin America Knee Pain Management Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Knee Pain Management Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Knee Pain Management Market Size and Volume Forecast by Types
     8.4.1. Acute Knee Pain
     8.4.2. Chronic Knee Pain
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Knee Pain Management Demand Share Forecast, 2019-2026
9. Europe Knee Pain Management Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Knee Pain Management Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Knee Pain Management Market Size and Volume Forecast by Types
     9.4.1. Acute Knee Pain
     9.4.2. Chronic Knee Pain
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Knee Pain Management Demand Share Forecast, 2019-2026
10. Asia Pacific Knee Pain Management Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Knee Pain Management Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Knee Pain Management Market Size and Volume Forecast by Types
     10.4.1. Acute Knee Pain
     10.4.2. Chronic Knee Pain
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Knee Pain Management Demand Share Forecast, 2019-2026
11. Middle East & Africa Knee Pain Management Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Knee Pain Management Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Knee Pain Management Market Size and Volume Forecast by Types
     11.4.1. Acute Knee Pain
     11.4.2. Chronic Knee Pain
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Knee Pain Management Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Knee Pain Management Market: Market Share Analysis
  12.2. Knee Pain Management Distributors and Customers
  12.3. Knee Pain Management Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Johnson & Johnson Services, Inc.
     12.4.2. F. Hoffman-La Roche AG
     12.4.3. Amgen, Inc.
     12.4.4. Merck & Co., Inc.
     12.4.5. Pfizer, Inc.
     12.4.6. Ferring B.V.
     12.4.7. GlaxoSmithKline plc
     12.4.8. Bayer AG
     12.4.9. AstraZeneca
     12.4.10. Sanofi S.A.